Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
20153.4k citationsBernd Zetsche, Jonathan S. Gootenberg et al.Cellprofile →
Rationally engineered Cas9 nucleases with improved specificity
20151.8k citationsIan M. Slaymaker, Linyi Gao et al.Scienceprofile →
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
20161.7k citationsOmar O. Abudayyeh, Jonathan S. Gootenberg et al.Scienceprofile →
Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA
2016552 citationsTakashi Yamano, Hiroshi Nishimasu et al.Cellprofile →
Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28
2017434 citationsAaron A. Smargon, David Cox et al.Molecular Cellprofile →
Directed evolution of adenine base editors with increased activity and therapeutic application
2020341 citationsNicole M. Gaudelli, Dieter K. Lam et al.Nature Biotechnologyprofile →
Base editing: advances and therapeutic opportunities
2020309 citationsAlexis C. Komor, Ian M. Slaymaker et al.Nature Reviews Drug Discoveryprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Ian M. Slaymaker
Since
Specialization
Citations
This map shows the geographic impact of Ian M. Slaymaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Slaymaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Slaymaker more than expected).
Fields of papers citing papers by Ian M. Slaymaker
This network shows the impact of papers produced by Ian M. Slaymaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Slaymaker. The network helps show where Ian M. Slaymaker may publish in the future.
Co-authorship network of co-authors of Ian M. Slaymaker
This figure shows the co-authorship network connecting the top 25 collaborators of Ian M. Slaymaker.
A scholar is included among the top collaborators of Ian M. Slaymaker based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Ian M. Slaymaker. Ian M. Slaymaker is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Gaudelli, Nicole M., Dieter K. Lam, Holly A. Rees, et al.. (2020). Directed evolution of adenine base editors with increased activity and therapeutic application. Nature Biotechnology. 38(7). 892–900.341 indexed citations breakdown →
4.
Komor, Alexis C., et al.. (2020). Base editing: advances and therapeutic opportunities. Nature Reviews Drug Discovery. 19(12). 839–859.309 indexed citations breakdown →
Smargon, Aaron A., David Cox, Neena Pyzocha, et al.. (2017). Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28. Molecular Cell. 65(4). 618–630.e7.434 indexed citations breakdown →
Abudayyeh, Omar O., Jonathan S. Gootenberg, Silvana Konermann, et al.. (2016). C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 353(6299). aaf5573–aaf5573.1689 indexed citations breakdown →
12.
Yamano, Takashi, Hiroshi Nishimasu, Bernd Zetsche, et al.. (2016). Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA. Cell. 165(4). 949–962.552 indexed citations breakdown →
13.
Slaymaker, Ian M., Linyi Gao, Bernd Zetsche, et al.. (2015). Rationally engineered Cas9 nucleases with improved specificity. Science. 351(6268). 84–88.1786 indexed citations breakdown →
14.
Zetsche, Bernd, Jonathan S. Gootenberg, Omar O. Abudayyeh, et al.. (2015). Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System. Cell. 163(3). 759–771.3404 indexed citations breakdown →
15.
Slaymaker, Ian M., Linyi Gao, Bernd Zetsche, et al.. (2015). Rationally engineered Cas9 nucleases with improved specificity. DSpace@MIT (Massachusetts Institute of Technology).3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.